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Background
A population (30%) of hydrocephalic hyh mutant mice
develop a slowly progressive hydrocephalus and survive
for periods ranging between 2 months and 2 years. Cer-
tain characteristics of these mice, such as time of onset of
hydrocephalus, type of abnormality of CSF dynamics,
clinical evolution and survival/death rate, resemble sev-
eral types of human congenital hydrocephalus. They rep-
resent an exceptional animal model to investigate
neuropathological and physiopathological aspects of a
brain "adapting" to a virtually life-lasting hydrocephalus
Materials and methods
(i) The clinical evolution of more than 3,000 hyh mice,(ii)
certain cellular and molecular aspects involved in the
pathogenesis of hydrocephalus of several hundreds of
embryos and postnatal hyh specimens and, (iii) the neu-
ropathology of more than one hundred hydrocephalic
mice with arrested hydrocephalus have been investigated
with a large series of techniques.
Results
The events occurring in the brain of aging hydrocephalic
mice may be regarded as loss and gain. Loss: Neuroepithe-
lium/ependyma denudation is a severe loss, since it leads
to (i) Sylvius aqueduct obliteration and severe hydroceph-
alus; (ii) abnormal development of certain populations of
cerebral neurons resulting in a permanent neurological
impairment. Abnormalities in the subcommissural organ
contribute to the development of hydrocephalus and to
changes in the protein composition of CSF. Severe altera-
tions of hypothalamus lead to neuroendocrine deficien-
cies. Gain: (i) A subpopulation of astrocytes responds to
denudation by repairing the denuded areas forming an
ependymal-like new barrier. (ii) Once severe hydrocepha-
lus has been turned on, two ependymal populations
located in the aqueduct and third ventricle start to prolif-
erate allowing the large expansion of these cavities. This
ependymogenesis continues for several weeks after birth.
(iii) All mice surviving hydrocephalus developed sponta-
neous ventriculostomies.
Conclusion
(i) Essential events of the hydrocephalic phenomenon
occur at a rather well defined temporal and spatial pattern
in which a program of sequential events may be envis-
aged. (ii) None of the pathological events should be
regarded as the result of mechanical phenomena. Rather,
abnormalities occurring at molecular and cellular levels
and leading to ependymal denudation and abnormal
neurogenesis, precede the onset of hydrocephalus. (iii)
Postnatal ependymogenesis and spontaneous ventriculos-
tomies are essential for the hydrocephalic mice to live a
long life.
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